Publications by authors named "Jeremie Haffner"

Objective: •To compare magnetic resonance imaging (MRI)-targeted biopsies with extended systematic biopsies for the detection of significant prostate cancer.

Methods: •In all, 555 consecutive patients with suspicion of prostate cancer had pre-biopsy dynamic contrast-enhanced 1.5-tesla (T) MRI with pelvic coil, 10-12 transrectal ultrasound-guided extended systematic biopsies plus two targeted biopsies at any MRI area suspicious for malignancy.

View Article and Find Full Text PDF

Purpose Of Review: To review the current status of MRI techniques in identification of organ-confined prostate cancer with a focus on their implication for focal therapy and active surveillance.

Recent Findings: MRI is currently focusing on intraprostatic prostate cancer identification and at 1.5T, it provides excellent imaging of the whole gland including the challenging anterior part.

View Article and Find Full Text PDF

Prostate cancer can be diagnosed by individual screening (digital examination and PSA assay at age > 50 y) when still localized and asymptomatic. The diagnosis is confirmed by staged biopsies and by magnetic resonance imaging (MRI) with targeted biopsies. A better knowledge of the natural history of prostate cancer, together with improvements in MRI, can help to predict the location, volume, local extension and prognosis prior to treatment.

View Article and Find Full Text PDF

Background: To describe the precise location of peripheral zone (PZ) prostate cancers at various stages of development and to demonstrate their pattern of intraprostatic spread from their site of origin.

Methods: PZ cancers defined as cancers located in peripheral zone (PZ) including the anterolateral part of PZ, were identified from radical prostatectomy specimens. PZ cancers morphometric histopathological study included largest surface area, volume and spatial distribution.

View Article and Find Full Text PDF

Introduction: Gastric or duodenal metastases from clear cell renal cell carcinoma are exceptional. According to autopsy series, the incidence of gastrointestinal metastases is 0.06 to 4% for all cancers and 0.

View Article and Find Full Text PDF

Objective: To describe the management of patients with locally advanced prostate cancer in France and the changes in this management between 2000 and 2003.

Material And Methods: Observational survey on a sample of urologists and radiotherapists throughout France, comprising 2 aspects: a retrospective aspect (patients diagnosed and treated in 2000) and a prospective aspect (patients diagnosed in 2003 during the survey period). Eligible patients presented locally advanced prostate cancer (T3, biopsy pT3, T4, NO-N1-Nx, M0), not treated in the context of a therapeutic trial.

View Article and Find Full Text PDF